Cargill receives GRAS no objections letter from FDA for EpiCor yeast fermentate as ISAPP defines ‘postbiotics’

Unlike probiotics, which are ‘live’ microbes, postbiotics are not ‘live’ and therefore can be used in a wider variety of products that don’t need refrigeration or special processing conditions to maintain their viability, making them attractive to food and beverage formulators.

Acquired by Cargill as part of its 2017 acquisition of Diamond V Mills, EpiCor​​​ is a heat- and pH-stable yeast fermentate made with a proprietary Non GMO strain of Saccharomyces cerevisiae​​ (baker’s yeast).

An umami-tasting shelf-stable powder that can be described on US ingredients lists as ‘yeast fermentate,’ ‘dried yeast fermentate’ or ‘yeast fermentate made with Saccharomyces cerevisiae​,’ EpiCor is highly soluble and dispersible in water (although not 100% soluble) and has a three-year shelf-life when stored as recommended in a dry environment in its original closed container.

According to Cargill’s GRAS determination​​​, EpiCor can be used in a wide range of foods, including cookies, meal replacement and probiotic beverages, nutritional bars, soy milk, yogurt and yogurt beverages, soy protein bars, fruit beverages, chocolate confections, and soups.

‘Like a multivitamin for your immune system’​

The fact that EpiCor’s health benefits are backed by eight peer-reviewed human clinical studies – six of which are double-blinded, placebo-controlled ‘gold standard’ trials – gives it a significant advantage over many other functional ingredients trying to cross over from supplements into food & beverage, Cargill Health Technologies president Chuck Warta told FoodNavigator-USA in a recent interview.

Source link

We will be happy to hear your thoughts

Leave a reply

Out Put Source
Enable registration in settings - general
Compare items
  • Total (0)
Shopping cart